Pharm
Glecaprevir Pibrentasvir
search
Glecaprevir Pibrentasvir
, Glecaprevir/Pibrentasvir, Mavyret
See Also
Hepatitis C Antiviral Regimen
Hepatitis C
Precautions
See
Hepatitis C Antiviral Regimen
Indications
See
Hepatitis C Antiviral Regimen
Gene
ral
Initial therapy for any
Genotype
in patients without
Cirrhosis
(or with Class A compensated
Cirrhosis
)
Salvage therapy for failed initial protocol for up to 16 weeks
Genotype
s
Hepatitis C
Genotype
1a
Hepatitis C
Genotype
1b
Hepatitis C
Genotype
2
Hepatitis C
Genotype
3
Hepatitis C
Genotype
4
Hepatitis C
Genotype
5 or 6
Contraindications
See
Hepatitis C Antiviral Regimen
Advanced
Cirrhosis
with Child Pugh Class B or C (or CTP score >=7)
No restriction based on
Renal Function
Mechanism
Glecaprevir is a NS3/4A
Protease Inhibitor
(...previrs)
Pibrentasvir (Mavyret) is a NS5A
Protein
Inhibitor (...asvirs)
Dosing
Take three tablets once daily for 8 weeks
Evaluation
See
Hepatitis C Antiviral Regimen
for Pre and post-treatment protocols
Adverse Effects
See
Hepatitis C Antiviral Regimen
Common (>10%)
Headache
Fatigue
Serious
Liver
injury or hepatic failure
Do not use in Child Pugh Class B or C
Drug Interactions
See
Hepatitis C Antiviral Regimen
Safe drugs
No significant interactions with
Opioid Addiction
therapy (
Methadone
,
Buprenorphine
)
Proton Pump Inhibitor
s are safe to use with Mavyret
Amiodarone
is safe to use with Mavyret
Contraindicated drugs (or limited dosing)
Atazanavir
Carbamazepine
Cyclosporine
(at doses >100 mg/day)
Dabigatran
Darunavir
Digoxin
(reduce dose to 50%)
Efavirenz
Ethinyl Estradiol
Avoid use with
Ethinyl Estradiol
containing contraceptives
Herbals
St Johns Wort
Lopinavir
Phenobarbital
Phenytoin
Rifampin
Ritonavir
Statin
s
Atorvastatin
Lovastatin
Simvastatin
Limit
Rosuvastatin
to 5 to 10 mg/day
Lower
Pravastatin
dose 50%
Limit
Fluvastatin
and
Pitavastatin
to lowest effective dose
Monitoring
See
Hepatitis C Antiviral Regimen
Efficacy
Hepatitis C
clearance rate of >95% against all
Genotype
s
Resources
Mavyret (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7bf99777-0401-9095-8645-16c6e907fcc0
References
(2023) Presc Lett,
Hepatitis C
Treatment Overview, Resource #390902
Type your search phrase here